Matthew L. Posard

Companies

• Nautilus Biotechnology, Inc.Board member Jun 9, 2021 to now¹
• Halozyme TherapeuticsBoard member Mar 28, 2013 to now²
• Talis Biomedical CorpBoard member Feb 11, 2021 to Jun 12, 2023³
• DermTech, Inc.Board member Sep 9, 2019 to Jun 5, 2023⁴
• Cardiff Oncology, Inc.Chief Commercial Officer Aug 24, 2015 to Jan 6, 2016⁵
• IlluminaSr VP & GM, Consumer Genomics Mar 7, 2012 to May 30, 2013⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• HTHalozyme Therapeutics HALO58,839 shares⁷$7.2M at $122.96Sep 16, 2026
• NBNautilus Biotechnology, Inc. NAUT150,000 shares⁸$385.5K at $2.57Dec 1, 2021
• DDermTech, Inc.158,215 shares⁹Jun 1, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 16, 2026Sold 4,000 shares at $108.99 of Halozyme Therapeutics⁷
• Sep 16, 2026Sold 8,896 shares at $108.04 of Halozyme Therapeutics⁷
• Sep 16, 2026Sold 3,000 shares at $106.83 of Halozyme Therapeutics⁷
• Sep 16, 2026Sold 3,100 shares at $106.13 of Halozyme Therapeutics⁷
• May 5, 2026Granted 3,796 shares of Halozyme Therapeutics¹⁰
• May 1, 2025Granted 4,165 shares of Halozyme Therapeutics¹¹
• Aug 14, 2024Sold 9,881 shares at $57.70 of Halozyme Therapeutics¹²
• Aug 13, 2024Sold 10,000 shares at $56.19 of Halozyme Therapeutics¹²
• Aug 12, 2024Sold 10,000 shares at $55.72 of Halozyme Therapeutics¹²
• Jun 12, 2024Sold 10,000 shares at $50.62 of Halozyme Therapeutics¹³
• Jun 11, 2024Sold 10,000 shares at $50.01 of Halozyme Therapeutics¹³
• Apr 25, 2024Granted 6,501 shares of Halozyme Therapeutics¹⁴
• Jun 1, 2023Granted 35,714 shares of DermTech, Inc.⁹
• May 5, 2023Granted 8,065 shares of Halozyme Therapeutics¹⁵
• Dec 6, 2022Sold 10,000 shares at $56.12 of Halozyme Therapeutics¹⁶
• Dec 5, 2022Sold 10,000 shares at $55.74 of Halozyme Therapeutics¹⁶
• Dec 2, 2022Sold 10,000 shares at $58.80 of Halozyme Therapeutics¹⁶
• May 26, 2022Granted 26,480 shares of DermTech, Inc.¹⁷
• May 5, 2022Granted 6,206 shares of Halozyme Therapeutics¹⁸
• Dec 1, 2021Bought 10,000 shares at $4.45 of Nautilus Biotechnology, Inc.⁸
• Dec 1, 2021Bought 10,000 shares at $4.46 of Nautilus Biotechnology, Inc.⁸
• Dec 1, 2021Bought 10,000 shares at $4.50 of Nautilus Biotechnology, Inc.⁸
• Nov 30, 2021Bought 20,000 shares at $4.57 of Nautilus Biotechnology, Inc.⁸